Parexel International Competitors and Similar CompaniesClear all

Parexel International's competitors and similar companies include Synexus, ICON, PPD and Syneos Health.

	Parexel International Parexel International (MA) is a clinical research organization.	Synexus Synexus is a provider of patient recruitment, trial planning, management, and patient retention services.	ICON ICON is a clinical research organization that provides consulting, outsourced development, and commercialization services.	PPD PPD (Pharmaceutical Product Development) is a company that provides drug development and laboratory solutions.	Syneos Health Syneos Health (formerly known as INC Research) is a biopharmaceutical solutions company.
Founding Date	Founding Date 1982	Founding Date 1992	Founding Date 1990	Founding Date 1985	Founding Date 1998
Type	Type Private	Type Subsidiary	Type Public	Type Subsidiary	Type Subsidiary
Tags	Tags Healthcare biotech clinical research pharma	Tags Healthcare biotech clinical research clinics	Tags Healthcare biotech clinical research medical imaging outsourcing	Tags Manufacturing & Industrial clinical research drug development pharma	Tags Healthcare biotech clinical research pharma
Locations	Locations Newton, US HQ Olivos, AR Vicente López, AR Brisbane, AU Macquarie Park, AU Wavre, BE Sao Paulo, BR see more	Locations Waterloo, GB HQ Wrocław, PL Tempe, US	Locations Dublin, IE HQ Villa Adelina, AR Sydney, AU Vienna, AT Minsk, BY Minsk, BY Mechelen, BE see more	Locations Wilmington, US HQ Buenos Aires, AR Melbourne, AU Brussels, BE Zaventem, BE São Paulo, BR São Paulo, BR see more	Locations Morrisville, US HQ Buenos Aires, AR Adelaide, AU Montréal, CA Québec, CA Toronto, CA Beijing, CN see more
Employees	Employees 20,806	Employees 3993% increase	Employees 41,250	Employees 24,5842% decrease	Employees 29,000
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) £88.6m (FY, 2019)	Revenue (est.) $8.3b (FY, 2024)	Revenue (est.) $4.7b (FY, 2020)	Revenue (est.) $5.4b (FY, 2022)
Cost of goods	Cost of goods N/A	Cost of goods £88.1m (FY, 2019)	Cost of goods N/A	Cost of goods $1.7b (FY, 2020)	Cost of goods $4.1b (FY, 2022)
Gross profit	Gross profit N/A	Gross profit £411k (FY, 2019)	Gross profit $8.3b (FY, 2024)	Gross profit $3b (FY, 2020)	Gross profit $1.3b (FY, 2022)
Net income	Net income N/A	Net income (£11.3m) (FY, 2019)	Net income $791.5m (FY, 2024)	Net income $160.6m (FY, 2020)	Net income $266.5m (FY, 2022)
Operating ⚠
Backlog	Backlog $4b (FY, 2017)	Backlog N/A	Backlog N/A	Backlog $9.5b (Q3, 2021)	Backlog $9.8b (Q1, 2023)
Countries	Countries 52 (FY, 2017)	Countries N/A	Countries 53 (FY, 2021)	Countries 46 (FY, 2020)	Countries 46 (FY, 2022)
Facilities	Facilities 8 (FY, 2017)	Facilities N/A	Facilities N/A	Facilities N/A	Facilities 96 (FY, 2022)